Eli Lilly | LLY - Nettoeinkommen





Nettoeinkommen Veränderung Datum
AbbVie USD 3.61B 2.92B 2026-06
Abbott USD 920M 8M 2026-09
ALKERMES USD 501K 66.98M 2026-06
Amgen USD 2.38B 556M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Baxter International USD 126M 141M 2026-06
Biogen USD 97.5M 222M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Coherus Biosciences USD -37.64M 2.11M 2025-12
Drreddys Laboratories INR 2.21B 9.89B 2026-03
Eli Lilly USD 7.1B 301M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
Glaxosmithkline GBP 1.74B 890.94M 2026-03
J&J USD 210M 5.32B 2026-09
Medtronic USD 1.47B 227M 2026-06
Merck USD -1.34B 2.9B 2026-06
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novartis USD 3.26B 108M 2026-06
Novartis USD 3.16B 747M 2026-03
Novo Nordisk DKK 20.99B 5.9B 2026-06
Perrigo USD 74.5M 473.1M 2026-06
Pfizer USD -248M 2.94B 2026-06
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 38.54M 15.39M 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Sanofi EUR 1.61B 2.42B 2026-03
United Therapeutics USD 333M 58.1M 2026-06
Zoetis USD 691M 90M 2026-06